Analysis of the expression of p53 during the morphogenesis of the gastroesophageal mucosa of Gallus gallus domesticus (Linnaeus, 1758).

Cell Tissue Res

Postgraduate Program in Animal Biology, Universidade Federal Rural do Rio de Janeiro, BR 465, KM 7, CEP 23.897-000, Seropédica, RJ, Brazil,

Published: January 2014

Ontogenesis comprises a series of events including cell proliferation and apoptosis and resulting in the normal development of the embryo. Protein p53 has been described as being involved in the development of several animal species. The aim of this study was to analyze the expression of protein p53 during the morphogenesis of the gastroesophageal mucosa of Gallus gallus domesticus and to correlate it with the histogenesis of structures present in this tissue. We used 24 embryos (at 12-20 days of incubation) and the thymus of two chickens. Immunohistochemical analysis was performed with the ABC indirect method. The expression of p53 in the gastroesophageal mucosa increased during the formation of the organ, mainly at the stages during which tissue remodeling and cell differentiation began. In the esophagus at stages 42 and 45, we observed immunoreactive (IR) cells in the surface epithelium and in early esophageal glands. In the proventriculus at stages 39-45, IR cells were present in the epithelial mucosa and rarely in the proventricular glands. In the gizzard after stage 42, we found IR cells mainly in the medial and basal epithelial layers of the mucosa and especially within the intercellular spaces that appeared at this phase and formed the tubular gland ducts. Thus, protein p53 occurs at key stages of development: in the esophagus during the remodeling of esophageal glands, in the proventriculus during the differentiation of the epithelium of the mucosa and in the gizzard during the formation of tubular glands.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00441-013-1720-9DOI Listing

Publication Analysis

Top Keywords

gastroesophageal mucosa
12
protein p53
12
expression p53
8
p53 morphogenesis
8
morphogenesis gastroesophageal
8
mucosa gallus
8
gallus gallus
8
gallus domesticus
8
esophageal glands
8
glands proventriculus
8

Similar Publications

Background: Previous research on the lower gastrointestinal tract has proved that microbial dysbiosis can lead to intestinal barrier dysfunction and enhanced visceral sensitivity, thus triggering bowel symptoms. Whether esophageal microbial dysbiosis also contributes to the development of gastroesophageal reflux (GER) symptoms, which are known to be associated with impaired esophageal barrier integrity, remains to be explored.

Methods: Patients with GER symptoms (gastroesophageal reflux disease [GERD] and functional esophageal disorders [FED]), duodenal ulcer patients and healthy controls were prospectively included for esophageal microbial analysis.

View Article and Find Full Text PDF

Vonoprazan is a novel acid blocker with greater potency than proton pump inhibitors. A Japanese study reported no significant safety concerns over 5 years of Vonoprazan use; however, elevated serum gastrin and increased parietal cell and foveolar hyperplasia were observed, and long-term safety data beyond 5 years are limited. We report a case that used Vonoprazan for 6 years, complicated by significant gastric epithelial changes during treatment and acute duodenal mucosal lesions following its discontinuation.

View Article and Find Full Text PDF

This study aims to report the dietary and daily management, clinical signs, complementary exams, and pathological findings related to an acute and fatal case of gastric dilatation and volvulus (GDV) in a captive Linnaeus's two-toed sloth () in the Amazon Biome. An adult female sloth, rescued after being electrocuted, was housed at the Wildlife Section of the Veterinary Hospital (WSVH) of the Institute of Veterinary Medicine (IVM) at the Universidade Federal do Pará (UFPA). It was fed a diverse diet that included animal protein, fruits, vegetables, and greens, with vitamin and mineral supplementation.

View Article and Find Full Text PDF

Established and Novel Methods to Assess GERD: An Update.

Visc Med

December 2024

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Background: Gastroesophageal reflux disease (GERD) is common. Management of reflux symptoms includes medical and nonmedical interventions. Proton pump inhibitors (PPIs) continue to be considered first-line agents.

View Article and Find Full Text PDF

Background Gastroesophageal reflux disease (GERD) is a condition characterized by reflux of gastric contents, leading to damage to the esophageal mucosa and/or unpleasant symptoms, with a global prevalence of 13%. Although acid-suppressive medications are currently the most effective treatments for GERD, they may be ineffective against its symptoms. We therefore investigated the efficacy of a physical exercise program for the treatment of intractable GERD symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!